The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2022 | The role of PET/CT in multiple myeloma
Jakob Nordberg Nørgaard, PhD, Oslo University Hospital, Oslo, Norway, outlines the role of PET/CT in the diagnosis and management of multiple myeloma. PET/CT is a very sensitive technique used for the diagnosis of extramedullary disease and osteolytic lesions, as well as for risk stratification and response assessment. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
